Anja Mueller

Prof. Dr. Anja Mueller


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2002 in Blood
Verified
Journal Article
Closed access
PDF file
AMAnja Mueller
Anja Mueller
EKEamonn Kelly
Eamonn Kelly
PSPhilip G. Strange
Philip G. Strange
M-tropic human immunodeficiency virus (HIV-1) strains enter the cell after interaction with their receptors, CD4 and the G-protein–coupled chemokine receptor CCR5. The number of cell surface CCR5 molecules is thought to be important in determining the infection rate for HIV. Cell surface CCR5 is dependent on the rate of receptor internalization and recycling. Internalization of G-protein–coupled receptors after agonist activation is thought to occur either through clathrin-coated pits or through caveolae. In this study, the role of these different pathways was investigated in Chinese hamster ovary cells expressing CCR5 using specific inhibitors. Internalization of CCR5 after chemokine treatment was inhibited by sucrose, indicating a role for the clathrin-coated pit pathway. Activation of CCR5 leads to arrestin-2 movement in the cells, providing further evidence for the involvement of clathrin-coated pits. Nystatin and filipin also affected the rate of internalization of CCR5, indicating a role for caveolae. Using inhibitors of vesicle transport in the cell, it was found that the CCR5 recycling pathway is independent of the Golgi apparatus and late endosomes. Protein synthesis is not involved in receptor recovery. It seems likely that after internalization, CCR5 is directed to early endosomes and subsequently recycled to the cell surface.

1 June 2021 in Biochemical Society Transactions
Verified
Journal Article
Open access
PDF file
WLWing Yee Lai
Wing Yee Lai
AMAnja Mueller
Anja Mueller
The chemokine system plays a fundamental role in a diverse range of physiological processes, such as homeostasis and immune responses. Dysregulation in the chemokine system has been linked to inflammatory diseases and cancer, which renders chemokine receptors to be considered as therapeutic targets. In the past two decades, around 45 drugs targeting chemokine receptors have been developed, yet only three are clinically approved. The challenging factors include the limited understanding of aberrant chemokine signalling in malignant diseases, high redundancy of the chemokine system, differences between cell types and non-specific binding of the chemokine receptor antagonists due to the broad ligand-binding pockets. In recent years, emerging studies attempt to characterise the chemokine ligand–receptor interactions and the downstream signalling protein–protein interactions, aiming to fine tuning to the promiscuous interplay of the chemokine system for the development of precision medicine. This review will outline the updates on the mechanistic insights in the chemokine system and propose some potential strategies in the future development of targeted therapy.

1 November 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
EAEnana Alassaf
Enana Alassaf
AMAnja Mueller
Anja Mueller

1 January 2018 in Cellular Signalling
Verified
Journal Article
Closed access
SMShirley C. Mills
Shirley C. Mills
LHLesley Howell
Lesley Howell
ABAndrew Beekman
Andrew Beekman
LSLeanne Stokes
Leanne Stokes
AMAnja Mueller
Anja Mueller

23 December 2010 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
AMAnja Mueller
Anja Mueller
RLRuth Lalor
Ruth Lalor
CCClara Moyano Cardaba
Clara Moyano Cardaba
Susan MatthewsSusan Matthews
Susan Matthews
The uptake of a fluorescently labeled cationic calix[4] (NBDCalAm) in live, nonfixed cells has been investigated. The compound is taken into the cells rapidly and shows distinct endosomal distribution after 2 hours. This distribution pattern shows colocalization with lysosomal staining. The uptake is not altered by inhibition of clathrin or caveolae dependent pathways nor by depletion of the cellular ATP‐pool. Immediately after uptake the probe is localized in the Golgi and brefeldin A treatment prevents transport to lysosomes. Pulse chase experiments with bafilomycin A1, monensin, and sodium azide showed that accumulation and retention of the probe in lysosomes is primarily driven by the activity of vacuolar ATPases. The NBD labeled calix[4]arene provides a very stable and sensitive marker for lysosomes, and has a considerable advantage over some commercially available lysosomal markers in so far that the fluorescent signal is stable even when the cells are incubated in dye‐free medium after staining. © 2010 International Society for Advancement of Cytometry

1 April 2016 in Cellular Signalling
Verified
Journal Article
Closed access
SMShirley C. Mills
Shirley C. Mills
HGHui Poh Goh
Hui Poh Goh
JKJossie Kudatsih
Jossie Kudatsih
SNSithembile Ncube
Sithembile Ncube
RGRenu Gurung
Renu Gurung
AMAnja Mueller
Anja Mueller